General Pharmaceuticals Market Research Reports & Industry Analysis
General Pharmaceuticals Industry Research & Market Reports
-
Betaine
... 4.6% over the analysis period 2024-2030. Synthetic, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in ... Read More
-
Active Pharmaceutical Ingredients (API)
... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Innovative, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$240.8 Billion by the end ... Read More
-
Marijuana Drying and Curing Equipment
... Million by 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$55.2 Million While China is Forecast to Grow at 8.7% CAGR The Marijuana Drying and ... Read More
-
Botanical Extracts
... CAGR of 8.6% over the analysis period 2024-2030. Spices, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$4.8 Billion by the end of the analysis period. ... Read More
-
Synthetic Antioxidants
... CAGR of 6.1% over the analysis period 2024-2030. Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.4 Billion by the end of the analysis period. ... Read More
-
Sodium Bromide
... CAGR of 6.2% over the analysis period 2024-2030. Powder, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.7 Billion by the end of the analysis period. ... Read More
-
Anti-Ischemic Agents
... CAGR of 6.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$94.1 Million While China is Forecast to Grow at 9.7% CAGR The Anti-Ischemic Agents market in the U.S. is estimated at ... Read More
-
Triacetin
... 4.3% over the analysis period 2024-2030. Plasticizer, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$193.2 Million by the end of the analysis period. Growth in ... Read More
-
Track Etched Membranes
... at a CAGR of 10.1% over the analysis period 2024-2030. Membrane Filters, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$855.4 Million by the end of ... Read More
-
Pharmaceutical Excipients
... CAGR of 4.5% over the analysis period 2024-2030. Organic Chemicals, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.8 Billion by the end of the analysis ... Read More
-
Isosorbide
... 7.4% over the analysis period 2024-2030. PEIT, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$439.5 Million by the end of the analysis period. Growth in ... Read More
-
High Potency APIs (HPAPIs)
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Captive, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$34.8 Billion by the end ... Read More
-
Empty Capsules
... CAGR of 5.5% over the analysis period 2024-2030. Gelatin, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$3.5 Billion by the end of the analysis period. ... Read More
-
Curcumin
... 8.5% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$73.0 Million by the end of the analysis period. Growth in ... Read More
-
Dry Herb Cannabis Vaporizers
... 2030, growing at a CAGR of 15.2% over the analysis period 2024-2030. Tabletop, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.0 Billion by the end ... Read More
-
Cannabis Drinks Market Size, Share, and Outlook, 2025 Report- By Type (Cannabis Infused Wine, Cannabis-Infused Beer, Cannabis Infused Water, Cannabis Infused Coffee, Cannabis Infused Tea, Cannabis Infused Juice, Others), Flavor (UnFlavored, Fruit, Apple Cider, Black Tea, Cappuccino, Caramel), Component (Tetrahydrocannabinol (THC) Infused Drinks, Cannabidiol (CBD) Infused Drinks, Others), Distribution Channel (Supermarkets and Hypermarkets, Convenience stores, Specialty stores, Online), and Companies, 2021-2032
... market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on ... Read More
-
Ophthalmic Eye Dropper
... at a CAGR of 3.8% over the analysis period 2024-2030. Preserved multi-Dose Eye Droppers, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$10.3 Billion by the ... Read More
-
DPP-IV Inhibitors
... CAGR of 1.7% over the analysis period 2024-2030. The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 1.7% CAGR The DPP-IV Inhibitors market in the U.S. is estimated at ... Read More
-
Cannabis Pharmaceuticals
... CAGR of 55.1% over the analysis period 2024-2030. Sativex Brand, one of the segments analyzed in the report, is expected to record a 60.1% CAGR and reach US$52.6 Billion by the end of the analysis ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis period. ... Read More
-
CBD Gummies
... CAGR of 28.8% over the analysis period 2024-2030. Low, one of the segments analyzed in the report, is expected to record a 28.2% CAGR and reach US$32.4 Billion by the end of the analysis period. ... Read More
-
Castor Oil and Derivatives
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Sebacic Acid, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$557.8 Million by the ... Read More
-
Iridium
... 5.3% over the analysis period 2024-2030. Automobile, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in ... Read More
-
Potassium Bromide
... CAGR of 4.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.5 Million While China is Forecast to Grow at 7.8% CAGR The Potassium Bromide market in the U.S. is estimated at ... Read More
-
Constipation Treatment
... CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
Research Assistance
